Abstract:
The present invention relates to a composition comprising an Amorpha fruticosa extract for PTP inhibition and PPAR activation. The composition of the present invention is capable of reducing blood glucose by increasing susceptibility to insulin as both of activation and expression of PTP1B are inhibited, and shows an outstanding activity for glucose uptake in muscle cells. [Reference numerals] (AA) Normal condition; (BB,FF,II,KK) Control group; (CC,GG) Example ; (DD,HH) Example ; (EE) Insulin resistance condition; (JJ,LL) Example
Abstract:
PURPOSE: A processed ginseng extract is provided to contain a large amount of ginsenoside Rg3, Rg5, Rk1, and to selectively contain ginsenoside of 20 (S)-Rg3 or ginsenoside of 20 (R)-Rg3 depending on the desired effect. CONSTITUTION: A processed panax species plant extract is obtained by Maillard-browning a panax species plant extract with more than one amino acid selected from a group comprising arginine, alanine, and valine at 100-130 deg. C for 0.5-12 hours. The processed panax species plant extract is obtained by Maillard-browing the panax species plant extract with more than one amino acid selected from a group comprising leucine and glutamine at 100-130 deg. C for 0.5-12 hours. A pharmaceutical composition for anti-cancer, neuroprotection, inhibition of platelet aggregating, anti-oxidation, anti-inflammation, kidney protection, and anti-fatigue comprises the panax species plant extract.
Abstract:
본 발명은 개느삼( Echinosophora koreensis ) 추출물, 개느삼 분획물, 이로부터 분리한 개느사논 H(kenusanone H) 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 항암제용 약학적 조성물에 관한 것으로서, 특히 개느삼 추출물로부터 분리한 단일 화합물인 개느사논 H는 시험관내( in vitro ) 및 생체내( in vivo ) 실험에서 암세포의 성장을 억제하므로 본 발명에 따른 조성물은 암을 치료하는데 유용하게 사용될 수 있다. 개느삼, 개느삼 추출물, 개느삼 분획물, 개느사논 H, 항암제, 종양 억제
Abstract:
PURPOSE: A composition containingi oleanonic acid for preventing or treating dementia is provided to suppress beta-amyloid generation. CONSTITUTION: A composition for preventing or treating neurodegenerative diseases contains oleanonic acid of chemical formula 1 or pharmaceutically acceptable salt thereof as an active ingredient. A composition for preventing or treating neurodegenerative diseases contains Patrinia scabiosaefolia extract, dried material of the extract, or concentrate of the extract as an active ingredient. The Patrinia scabiosaefolia extract is isolated using water or alcohol of C1-C4.
Abstract:
본 발명은 신규한 스핑고모나스 속( Sphingomonas ) 박테리아 균주 KMK-001을 액체배지에서 배양하고, 상기 박테리아 균주의 배양액에 액체배지에서 별도로 배양된 신규한 아스페질러스 속( Aspegillus ) 균주 KMC-901을 가하여 혼합배양하는 스핑고모나스 박테리아-아스페질러스 곰팡이의 혼합배양법, 이로부터 생합성된 신규한 글리오니트린(Glionitrins), 및 상기 글리오니트린 또는 이의 약학적으로 허용가능한 염을 유효성분으로 하는 약학적 조성물에 관한 것이다. 상기 글리오니트린은 암세포에 대하여 강한 세포독성 효과가 있고, 스핑고모나스 속 신규 박테리아 균주 KMK-001를 포함한 10종의 유해균에 대한 항생효과를 나타냄으로써 항암제 또는 항생제에 유용하게 이용될 수 있다. 스핑고모나스 속 박테리아, 아스페질러스 속 곰팡이, 스핑고모나스 박테리아-아스페질러스 곰팡이 혼합배양법, 글리오니트린(Glionitrins), 항암제, 항생제.
Abstract:
A stilbene derivatives as PPAR(peroxisome proliferator activation acceptor) alpha/gamma dual agonists is provided for treatment and prevention of obesity, diabetes, skin aging, skin wrinkle and skin hydration. A stilbene derivatives represented by the formula 1 is obtained by reacting a compound represented by the formula 2 and a compound represented by the formula 3. In the formula 1, 2 and 3, R^1 indicates an isoflavonoid group represented by the formula 1-a; R^2 is hydrogen, methyl, ethyl, tert-butyl, benzyl, methoxymethyl, trimethylsilyl, tert-butyldiphenylsilyl, tert-butyldimethylsilyl or triisopropylsilyl; R^3 shows -F, -CF3, -CH3 or -OCH3; A represents cis-, trans- isomers; m is an integer of 0~2; n is an integer of 1~5; p is integer of 0~2; and X shows a halogen atom.
Abstract translation:提供作为PPAR(过氧化物酶体增殖物激活受体)α/γ双重激动剂的二苯乙烯衍生物用于治疗和预防肥胖症,糖尿病,皮肤老化,皮肤皱纹和皮肤水合。 由式1表示的芪衍生物通过使式2表示的化合物与由式3表示的化合物反应而获得。在式1,2和3中,R 1表示由式1表示的异黄酮基, 一个; R 2是氢,甲基,乙基,叔丁基,苄基,甲氧基甲基,三甲基甲硅烷基,叔丁基二苯基甲硅烷基,叔丁基二甲基甲硅烷基或三异丙基甲硅烷基; R 3表示-F,-CF 3,-CH 3或-OCH 3; A代表顺式,反式异构体; m为0〜2的整数; n为1〜5的整数; p为0〜2的整数; X表示卤素原子。